Health status that allows for inpatient ERCP under sedation choledocholithiasis, pancreatic cancer, bile duct cancer
Conditions
Interventions
High flow nasal cannula
Sponsors
Takahashi Kosuke
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: i) Patients scheduled for inpatient endoscopic retrograde cholangiopancreatography (ERCP) under sedation ii) Age: Patients who are at least 18 years old and less than 85 years old. iii) Patients who have been fully informed about their participation in this study and who have given written consent of their own free will based on their full understanding of the study.
Exclusion criteria
Exclusion criteria: i) Patients receiving continuous oxygen administration by nasal cannula (home oxygen therapy) ii) Patients with a history of pneumothorax iii) Patients with a history of bronchial asthma attack or severe asthma iv) Patients participating in clinical trials or other clinical studies v) Other patients who are deemed inappropriate as research subjects by the principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of hypoxemia | — |
Secondary
| Measure | Time frame |
|---|---|
| i) Percentage of significant hyperCO2emia during venous anesthesia (transcutaneous CO2 concentration > 60 mmHg) ii) Percentage of moderate hyperCO2emia during venous anesthesia (transcutaneous CO2 concentration > 50 mmHg) iii) Area under the curve (AUC) of transcutaneous CO2 concentration per unit time during venous anesthesia iv)) Mean respiratory rate during venous anesthesia v) Total dose of sedative drug and dose per anesthesia hour vi) Total dose of sedative drug, dose per anesthesia hour vii) Ramsay scale score viii) Incidence of severe hypoxemia ix) Incidence of sustained hypoxemia (Definition of sustained hypoxemia: hypoxemia lasting more than 10 seconds) 10) ERCP bile duct intubation time, total procedure time | — |
Contacts
Public ContactKosuke Takahashi
Nagasaki University Hospital
Outcome results
None listed